
    
      Patients with NK/T cell lymphoma usually have a bad prognosis. These patients cannot be
      treated successfully with the conventional chemotherapy of CHOP.The investigators did this
      trial to evaluate the efficacy and tolerability of the combination chemotherapy of DICE in
      the patients with NK/T cell lymphoma.
    
  